Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Experience of adopting faecal immunochemical testing to meet the NICE colorectal cancer referral criteria for low-risk symptomatic primary care patients in Oxfordshire, UK.

Nicholson BD, James T, East JE, Grimshaw D, Paddon M, Justice S, Oke JL, Shine B.

Frontline Gastroenterol. 2019 Oct;10(4):347-355. doi: 10.1136/flgastro-2018-101052. Epub 2018 Oct 9.

PMID:
31656559
2.

Natriuretic peptide-guided treatment for heart failure: a systematic review and meta-analysis.

McLellan J, Bankhead CR, Oke JL, Hobbs FDR, Taylor CJ, Perera R.

BMJ Evid Based Med. 2020 Feb;25(1):33-37. doi: 10.1136/bmjebm-2019-111208. Epub 2019 Jul 20.

3.

Development of practical recommendations for diagnostic accuracy studies in low-prevalence situations.

Holtman GA, Berger MY, Burger H, Deeks JJ, Donner-Banzhoff N, Fanshawe TR, Koshiaris C, Leeflang MM, Oke JL, Perera R, Reitsma JB, Van den Bruel A.

J Clin Epidemiol. 2019 Oct;114:38-48. doi: 10.1016/j.jclinepi.2019.05.018. Epub 2019 May 28.

PMID:
31150837
4.

Development and validation of clinical prediction models to risk stratify patients presenting with small pulmonary nodules: a research protocol.

Oke JL, Pickup LC, Declerck J, Callister ME, Baldwin D, Gustafson J, Peschl H, Ather S, Tsakok M, Exell A, Gleeson F.

Diagn Progn Res. 2018 Nov 29;2:22. doi: 10.1186/s41512-018-0044-3. eCollection 2018.

5.

The mapping of cancer incidence and mortality trends in the UK from 1980-2013 reveals a potential for overdiagnosis.

Oke JL, O'Sullivan JW, Perera R, Nicholson BD.

Sci Rep. 2018 Oct 2;8(1):14663. doi: 10.1038/s41598-018-32844-x.

6.

Trends in Cancer Antigen 125 testing 2003-2014: A primary care population-based cohort study using laboratory data.

Nicholson BD, Lee MM, Wijeratne D, James T, Shine B, Oke JL.

Eur J Cancer Care (Engl). 2019 Jan;28(1):e12914. doi: 10.1111/ecc.12914. Epub 2018 Sep 20.

PMID:
30238522
7.

Early detection of multiple myeloma in primary care using blood tests: a case-control study in primary care.

Koshiaris C, Van den Bruel A, Oke JL, Nicholson BD, Shephard E, Braddick M, Hamilton W.

Br J Gen Pract. 2018 Sep;68(674):e586-e593. doi: 10.3399/bjgp18X698357. Epub 2018 Aug 13.

8.

Variation in Direct Access to Tests to Investigate Cancer: A Survey of English General Practitioners.

Nicholson BD, Oke JL, Rose PW, Mant D.

PLoS One. 2016 Jul 22;11(7):e0159725. doi: 10.1371/journal.pone.0159725. eCollection 2016.

9.

Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis.

Hill NR, Fatoba ST, Oke JL, Hirst JA, O'Callaghan CA, Lasserson DS, Hobbs FD.

PLoS One. 2016 Jul 6;11(7):e0158765. doi: 10.1371/journal.pone.0158765. eCollection 2016. Review.

10.

The use of statistical methodology to determine the accuracy of grading within a diabetic retinopathy screening programme.

Oke JL, Stratton IM, Aldington SJ, Stevens RJ, Scanlon PH.

Diabet Med. 2016 Jul;33(7):896-903. doi: 10.1111/dme.13053. Epub 2016 Jan 10. Erratum in: Diabet Med. 2019 Oct;36(10):1319.

11.

Comment on: 'Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960'--cancer predictions need more context.

Oke JL, Nicholson BD, Shinkins B.

Br J Cancer. 2015 Dec 1;113(11):1632. doi: 10.1038/bjc.2015.219. Epub 2015 Jun 23. No abstract available.

12.

Cancer survival figures are misleading.

Oke JL.

BMJ. 2014 May 19;348:g3315. doi: 10.1136/bmj.g3315. No abstract available.

PMID:
24840236
13.

Establishing an evidence base for frequency of monitoring glycated haemoglobin levels in patients with Type 2 diabetes: projections of effectiveness from a regression model.

Oke JL, Stevens RJ, Gaitskell K, Farmer AJ.

Diabet Med. 2012 Feb;29(2):266-71. doi: 10.1111/j.1464-5491.2011.03412.x.

PMID:
21838767

Supplemental Content

Support Center